Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing.

Zhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J, Tang H, Zhang Q. · 2023

Read Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. by Zhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J, Tang H, Zhang Q. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10134577.txt.

Introduction

Zhou and co-authors review exosomes from stem cells as a treatment to help wounds heal, in a 2023 paper. Wound healing moves through stages of clotting, inflammation, growth, and remodeling. Stem cells can aid that process, and much of their effect comes from tiny parcels they release, called exosomes.

The review explains how these parcels carry signals that calm inflammation and spur new tissue. It gathers lab and early clinical evidence across wound types. It also lists hurdles, such as making pure batches at scale, before such treatments reach routine care.

Catalog record

CREATORZhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J, Tang H, Zhang Q.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10134577

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing By Chuchao Zhou, Boyu Zhang, Yanqing Yang, Qiong Jiang, Tianyu Li, Jun Gong, Hongbo Tang, Qi Zhang Published in: Stem Cell Research & Therapy DOI: 10.1186/s13287-023-03345-0 ABSTRACT Wound healing is a dynamic and highly sequential process involving a series of overlapping spatial and temporal phases, including hemostasis, inflammation, proliferation, and tissue remodeling. Mesenchymal stem cells (MSCs) are multipotent stem cells with self-renewal, multidirectional differentiation potential, and paracrine regulation. Exosomes are subcellular vesicular components 30–150 nm in size and are novel carriers of intercellular communication in regulating the biological behaviors of skin cells. Compared to MSCs, MSC-derived exosomes (MSC-exos) possess lower immunogenicity, easy storage, and highly effective biological activity. MSC-exos, mainly derived from adipose-derived stem cells (ADSCs), bone marrow-derived MSCs (BMSCs), human umbilical cord MSCs (hUC-MSCs), and other stem cell types, play a role in shaping the activity of fibroblasts, keratinocytes, immune cells, and endothelial cells in diabetic wounds, inflammatory wound repair, and even wound-related keloid formation. Therefore, this study focuses on the specific roles and mechanisms of different MSC-exos in wound healing, as well as the current limitations and various perspectives. Deciphering the biological properties of MSC-exos is crucial to providing a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Graphical Abstract INTRODUCTION Skin wounds are caused by various intrinsic pathological and external mechanical factors that damage the structure or integrity of skin tissues [1]. Skin wounds can lead to a series of local and even systemic physiological and pathological changes, which result in a heavy burden on patients and society. Wound healing is a highly sequential process of skin barrier function restoration and consists of temporally overlapping and interdependent phases, including hemostasis, inflammation, proliferation, and tissue remodeling [2]. During these phases, there are dynamic interactions between numerous different types of skin cells and immune cells that function at specific stages to reshape the wound healing process [3] (Fig. 1). Currently, clinically conventional approaches, including various types of wound dressings, negative pressure suction, tissue engineering substitutes, and autologous skin grafts, are being employed to foster wound healing, but all have certain values and unsatisfactory points [4–6].Fig. 1Wound types, skin structure, and wound healing phases. a Different wound types, mainly including infectious, diabetic, tumor, pressure, burn, and other wounds, such as trauma, radiation, drug-induced, ischemia and venous congestion wounds. b The skin structure consists of three layers, the epidermis, dermis, and hypodermis. The epidermis is primarily composed of keratinocytes, melanocytes, and Langerhans cells, contributing to a natural barrier against foreign objects. The dermis is a region rich in fibroblasts and immune cells, as well as collagen fibers, elastic fibers, reticular fibers, nerve endings, and capillaries, for maintaining the density and tightness of skin structure. The underlying hypodermis consists of adipocytes and connective tissue, which is conducive to warmth, cushioning, and reduction of mechanical stress. c The phase of wound healing is temporally overlapping and interdependent, including hemostasis, inflammation, proliferation, and tissue remodeling. Fibroblasts, keratinocytes, and immune cells are important skin cells in wound healing phases. In this figure was partly generated using Servier Medical Art (https://smart.servier.com), provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license (https://creativecommons.org/licenses/by/3.0/) Mesenchymal stem cells (MSCs) are multipotent stem cells with self-renewal capability, multidirectional differentiation potential, and paracrine regulation [7]. Due to their easy isolation, in vitro expansion, and multipotent stemness, MSCs have been acknowledged as an important source of stem cells in the field of regenerative medicine, including tissue repair [8, 9]. In addition to MSCs in bone marrow, MSCs are also present in adipose, muscle, umbilical cord, several organs, and other tissues. Stem cells have excellent therapeutic effects in promoting skin remodeling, tissue vascularization, soft tissue regeneration, bone and cartilage repair, multi-tissue rejuvenation, and hair follicle regeneration. Presently, stem cells are primarily involved in facilitating skin wound healing through the paracrine function of multiple factors. Of note, the therapeutic utilization of stem cells in wound healing is also limited by storage challenges, mutation-related tumorigenicity, optimal cell activity, immune rejection, and ethical factors [10]. Exosomes are naturally occurring subcellular vesicular components 30–150 nm in size that can be secreted by almost all cells [11]. Exosomes are widely dispersed in body fluids, such as serum, saliva, milk, cerebrospinal fluid, urine, and semen [12]. Exosomes perform biological functions such as transmitting information, removing intracellular components, and acting as drug carriers by transporting a wide range of biologically active components that regulate physiological and pathological processes [13, 14]. Notably, stem cell exosomes possess unique biological functions similar to stem cells, as exosomes are the products and mappings of their parental cells. Stem cell exosomes are pivotal mediators of the biological effects of paracrine factors from stem cells, providing an ideal approach for further cell-free therapeutic wound healing [15]. MSC-derived exosomes (MSC-exos) also contain cytokines such as vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), interleukin-6 (IL-6), interleukin-10 (IL-10), and hepatocyte growth factor (HGF), which facilitate angiogenesis and immunomodulation [16]. The main packaging components of MSC-exos, including metabolites, proteins, DNA, and non-coding RNAs (ncRNAs), can be internalized by recipient cells, such as fibroblasts, keratin-forming cells, immune cells, and endothelial cells (ECs), and further promote better wound repair by improving wound circulation, promoting wound vascularization, modulating inflammatory stress states, and recruiting stem cells [17]. In addition, the repair efficacy of MSC-exos can be improved by targeted editing of exosome content, pretreatment of MSCs, or artificial modification of exosome surface molecular receptors. In summary, MSC-exos potentially possess specific application advantages over MSCs in promoting wound healing. Adipose-derived stem cells (ADSCs), bone marrow-derived MSCs (BMSCs), and human umbilical cord MSCs (hUC-MSCs) are the most frequently reported exosome-producing cells used for wound healing (Fig. 2). Therefore, this study focused on the specific roles and mechanisms of various MSC-exos in wound healing, demonstrating promising cell-free therapeutic strategies for wound healing and cutaneous regeneration.Fig. 2The compositions, biomarkers, and source of MSC-exos. Compared to normal exosomes, MSC-exos display similar compositions and biomarkers, which are related to biogenesis-related proteins (Alix, TSG101), membrane transport and fusion proteins (Annexin, Rab5), tetraspanins (CD81, CD63, CD9), specific receptor (EGFR), and antigen presentation (MHC, HLA-G). Various components, mainly metabolites, proteins, enzymes, HSPs, DNAs, mRNAs, miRNAs, lncRNAs, and circRNAs, are enclosed within MSC-exos. Multiple stem cell exosomes have good potential in wound healing, including ADSCs, BMSCs, hUC-MSCs, iPSCs, EPSCs, USCs, OMLP-PCs, MenSCs, WJ-MSCs, hAMSCs, hAFSCs, and hESCs. EGFR, epidermal growth factor receptor; MHC, major histocompatibility complex class; HLA-G, human leukocyte antigen-G; HSPs, heat shock proteins; mRNAs, messenger RNAs; miRNAs, microRNA; lncRNAs, long non-coding RNAs; circRNAs, circular RNAs. In this figure was partly generated using Servier Medical Art (https://smart.servier.com), provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license (https://creastivecommons.org/licenses/by/3.0/) ADSCS ADSCs are adipose tissue-derived MSCs that show self-renewal and multidirectional osteogenic, chondrogenic, and adipogenic differentiation [18]. ADSCs also possess the advantage of rich and wide sources, easy separation processes, low immunogenicity, and wide applications. Cell-free derivatives of ADSCs, including conditioned media, exosomes, and other active substances, induce paracrine effects and have been proposed as alternatives to traditional ADSC therapy [19]. In particular, due to their roles in regulating oxidative stress, immune cell infiltration, peri-wound vascularity, and inflammatory factor secretion in the wound microenvironment, ADSC-derived exosomes (ADSC-exos) are

Read the complete text